Dexcom Profit Margin

The latest profit margin for DXCM is 19.41% as of September 2026. That compares with 15.96% in the prior-year period — up 21.7% year over year. That is above the Healthcare sector average of 9.48%. Investors often review this figure alongside Dexcom's historical trend and sector peers before judging valuation or financial health.

Over the past year, DXCM's profit margin moved from 15.96% to 19.41% — a 21.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Dexcom's valuation or profitability profile.

Against Healthcare companies, DXCM currently prints 19.41% for profit margin, while the sector average sits near 9.48%. That is roughly 104.8% above the sector mean. Large gaps often invite a closer look at Dexcom's growth, margins, and balance sheet.

Profit Margin shows how effectively Dexcom converts resources into returns. At 19.41%, DXCM may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 15.96% in the prior-year period — up 21.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting DXCM's profit margin (19.41%), review year-over-year change from 15.96%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.